RETRACTED ARTICLE: The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway

Abstract

Prostate cancer (PCa) is a frequently occurring malignancy in males, and epithelial mesenchymal transition (EMT) plays a critical role in PCa metastasis. Thus, developing biomarkers inhibiting EMT may provide significance for treatment of PCa. Hence, the aim of the current study was to investigate the mechanism by which FBP1 gene silencing influences PCa cell EMT, invasion and metastasis by mediating the MAPK pathway. PCa cell lines exhibiting the highest FBP1 expression were selected and treated with plasmids of siRNA-FBP1 sequence 1 and 2, pcDNA3.1-Flag-FBP1 (over-expression plasmid of FBP1), U0126 (an inhibitor of the ERK signaling pathway) and PD98059 (an inhibitor of the MEK signaling pathway). Cell proliferation, migration and invasion were detected by MTT assay, wound healing assay and Transwell assay, respectively. The mRNA and protein expression of related factors of EMT and MAPK signaling were determined by RT-qPCR and western blot analysis, respectively. Xenograft tumor growth after inoculation of DU145 cells was regularly analyzed in the nude mice. The positive expression of EMT markers was determined by immunohistochemistry. DU-145 and PC-3 cells displaying the highest FBP1 expression were selected for further analysis. The PCa cells treated with siRNA-FBP1 exhibited increased proliferation, migration rate and invasion, in addition to facilitated xenograft tumor growth. Notably, siRNA-FBP1 was identified to accelerate PCa cell EMT by elevating the expression of Vimentin and N-cadherin while diminishing E-cadherin expression via activation of the MAPK signaling pathway. The aforementioned results were reversed in PCa cells treated by pcDNA3.1-Flag-FBP1. Evidence has been provided in this study that FBP1 gene silencing activates the MAPK pathway, which ultimately promotes cell EMT, invasion and metastasis in PCa.

Fructose‐1,6‐bisphosphatase aggravates oxidative stress‐induced apoptosis in asthma by suppressing the Nrf2 pathway

“…Fructose‐1,6‐bisphosphatase (Fbp1) is a rate‐limiting enzyme of gluconeogenesis that catalyses the splitting of fructose‐1,6‐bisphosphate into fructose 6‐phosphate and inorganic phosphate 8 . Fbp1 reportedly plays a critical role in several diseases, including type 2 diabetes mellitus, 9 cancers 10‐12 and acute liver failure 13 . Kaur et al 9 reported that Fbp1 can be considered a potential target for the treatment of type 2 diabetes.…”

A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma

“…FBP1 overexpression inhibits the proliferation, migration, invasion and tumorigenesis of cholangiocarcinoma cells by inhibiting the Wnt/β pathway [ 33 ]. FBP1 gene silencing could activate the MAPK pathway and then promote cell EMT, invasion and metastasis in prostate cancer [ 34 ]. Several studies have found that PLOD2 induces epithelial-mesenchymal transition (EMT) mainly through the PI3K / AKT signaling pathway [ 11 ].…”

Downregulation of Snail by DUSP1 Impairs Cell Migration and Invasion through the Inactivation of JNK and ERK and Is Useful as a Predictive Factor in the Prognosis of Prostate Cancer

“…Consistently with DUSP1 effects on MAPK activity, the ERK pathway is one of the major oncogenic signals in human cancers because its activation leads to an increase in proliferation, invasion, and metastasis [ 32 ]. Particularly in prostate cancer, the ERK pathway is often hyperactivated [ 33 ], acts as an inducer of cell migration and invasion [ 34 , 35 ] through a Snail-mediated mechanism [ 36 ], and is involved in the effects of different molecules on these processes [ 37 , 38 , 39 ]. In addition, the JNK pathway has also been described to be important as a pro-tumorigenic signal through Snail regulation in different tumors [ 40 , 41 , 42 ].…”